V. Bryan Lawlis
Equibles does not estimate personal net worth.
About V. Bryan Lawlis
Earlier roles on record: Board Member at Spyre Therapeutics, Inc. (SYRE) until June 22, 2023. Spyre Therapeutics, Inc. reported in an 8-K filed June 23, 2023 that V. Bryan Lawlis resigned as Board and any respective committee of the Board, effective June 22, 2023.
“on June 22, 2023, immediately prior to the effective time of the merger (“Effective Time”), Armen Shanafelt, Ph.D., V. Bryan Lawlis, Ph.D. and Marcio Souza, M.B.A. resigned from the Board and any respective committee of the Board to which they were members.”
Affiliation history
-
2018-01-01–2023-06-22